Goldman Sachs is down 6% over the past month, trading near $976, with peers falling in lockstep — and the question heading into October 13 Q3 results is whether this is sector rotation or something more specific to the franchise.
The sector selloff has been broad and indiscriminate. Morgan Stanley dropped 4.6% on the week. BNY fell 5%. Evercore lost 8.4%. Jefferies was the worst of the group, down more than 12%. Against that backdrop, GS's 5.8% weekly decline looks closer to the middle of the pack than a stock-specific story. The move takes the price back to levels last seen in May, erasing a chunk of the summer rally that had carried GS well above $1,000.
Short positioning has continued to tick higher, as flagged in the note published earlier this week, but the story remains one of direction rather than scale. Short interest is now 2.2% of the free float, up roughly 11% over the past month. That is still a low absolute level. Borrow remains trivially cheap at 0.36%, and availability is effectively unlimited — over 224 million shares available against a short position of around 7 million. There is no squeeze pressure, no borrow friction, and no sign that short sellers are making an aggressive directional call. The ORTEX short score has nudged up from the low 32s to 33.7, but that reading places GS in neutral territory, not under meaningful speculative stress. Options positioning is similarly relaxed: the put/call ratio is 0.87, almost exactly in line with its 20-day average, with a z-score near zero. Neither the lending market nor the options market is pricing in elevated risk.
The Street narrative for GS is a study in divergence between bullish structural confidence and near-term caution on valuation. Most of the analyst action occurred around the Q2 print in mid-July, when a cluster of firms raised targets in response to strong results — Barclays to $1,245, BofA to $1,300, Evercore ISI to $1,210, and Citigroup to $1,200. The mean consensus target is $1,142, implying roughly 17% return potential from current levels. But JPMorgan's target sits at just $955 — below where the stock is trading — and BMO trimmed its target after the quarter, even as peers raised theirs. UBS, in the most recent action (August 3), lifted to $1,150 while staying at Neutral. The bull case centres on Goldman's deepening shift toward fee-based asset and wealth management revenues, which reduce dependence on the more volatile trading and capital markets lines. Bears point to the continued reliance on investment banking cycle revenues and the risk that an economic slowdown compresses deal flow and trading income. At 13.5x trailing earnings and 2.5x book, the valuation has drifted lower over the past month — PE down about 0.75 turns, PB down 0.14 — reflecting the price correction rather than any earnings revision.
The factor picture adds a useful layer of nuance. GS scores in the 89th percentile on EPS surprise and 92nd on 90-day EPS momentum — a strong signal that the firm has been consistently beating estimates and that forward numbers are being revised upward on a medium-term view. The 30-day EPS momentum score is weaker, at the 31st percentile, suggesting the pace of near-term upgrades has slowed. The dividend score ranks in the 92nd percentile. Insider activity over the past 90 days has been net negative — the Chief Administrative Officer made several open-market sales between July and August, totalling around $1.1 million in aggregate value. These were not under a 10b5-1 plan, though the lot sizes and significance scores are modest. No C-suite buying has appeared in the recent window.
With Q3 results due October 13, the prior two earnings prints provide some context on what kind of moves the stock can produce. The July 2026 Q2 report delivered a 10.2% single-day gain, with the stock holding most of that over the following week. The April 2026 Q1 print was far quieter, a 0.3% decline on the day. The asymmetry in those reactions — one large beat, one near-flat — suggests the stock is capable of big moves when results surprise but does not give back much on inline prints. What to watch into October is whether the current price weakness into results reflects genuine repositioning ahead of a more uncertain quarter, or simply the sector-wide de-rating that has hit every large financial this month.
See the live data behind this article on ORTEX.
Open GS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
